| Name | Title | Contact Details |
|---|
TIXiMED, Inc. is focused on developing and commercializing TXNIP inhibiting medication as a first-of-its-kind oral therapeutic for Type 1 and Type 2 diabetes. TIXiMED is the exclusive license holder for the patent (composition of matter and method of use) surrounding TIX100, a novel small molecule that normalizes pancreatic beta cell TXNIP, a detrimental protein elevated in Type 1 and Type 2 diabetes. Increased TXNIP causes pancreatic islet dysfunction and death of insulin-producing beta cells and thereby contributes to the development and progression of diabetes. Diabetes affects more than half a billion people worldwide. Those affected by Type 1 diabetes are dependent on multiple daily insulin injections or continuous insulin infusions to stay alive and manage their blood sugar. Oral anti-diabetic drugs are only approved for Type 2 diabetes, but can be associated with multiple side effects, underlining the need for novel and better oral diabetes medications for Type 1 and Type 2 diabetes. TXNIP inhibition has recently been demonstrated to be an effective and safe therapeutic approach in adults and children with recent onset Type 1 diabetes and TIX100 shows beneficial, anti-diabetic effects in 4 different mouse models. Advantages of TIX100 include oral availability, no associated hypoglycemia or weight gain, potent inhibition of detrimental TXNIP in human islets, and a favorable pharmacokinetic and safety profile. In addition, TIX100 inhibits excessive glucagon secretion and hepatic glucose production and protects against fatty liver. Thus, TIX100 holds promise for durable, weight-neutral improvement in glycemic control in Type 1 and Type 2 diabetes by targeting common underlying pathology and promoting patients own islet cell health.
Steadfast Living offers pet-friendly apartments for rent across North America. Visit us today to learn more about finding the perfect community for you.
Nashville Zoo is a Nashville, TN-based company in the Business Services sector.
Dincher and Dincher Tree Surgeon is a Williamsport, PA-based company in the Business Services sector.
Deliv is a crowdsourced, same-day delivery service that extends the reach of omnichannel retailers and helps them enhance their customer experience by giving customers the choice to receive their items whenever and wherever they want. Deliv allows retailers to offer their customers a same-day delivery option as they shop from their website, mobile app or from their physical brick and mortar store. By simply adding the Deliv same-day delivery option into their existing checkout process, the retailer preserves the customer shopping experience, fulfils orders from inventory from their local brick and mortar stores all while maintaining ownership and data from each customer transaction. Deliv has partnered with over 225 national and regional retailers, as well as the nation`s four largest mall operators, who manage nearly 800 malls across the country. Deliv is headquartered in Menlo Park, California, and is backed by some of Silicon Valley’s leading venture capital firms.